Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1927 1
1928 1
1965 1
1970 1
1972 2
1976 2
1980 2
1984 3
1985 4
1986 4
1987 86
1988 231
1989 246
1990 231
1991 222
1992 291
1993 298
1994 327
1995 335
1996 311
1997 337
1998 367
1999 384
2000 445
2001 439
2002 570
2003 571
2004 579
2005 702
2006 780
2007 765
2008 823
2009 794
2010 934
2011 974
2012 1037
2013 1241
2014 1870
2015 2291
2016 2644
2017 2803
2018 2927
2019 3100
2020 3153
2021 257
Text availability
Article attribute
Article type
Publication date

Search Results

29,825 results
Results by year
Filters applied: . Clear all
Page 1
Microbiome and pancreatic cancer: A comprehensive topic review of literature.
Ertz-Archambault N, Keim P, Von Hoff D. Ertz-Archambault N, et al. World J Gastroenterol. 2017 Mar 14;23(10):1899-1908. doi: 10.3748/wjg.v23.i10.1899. World J Gastroenterol. 2017. PMID: 28348497 Free PMC article. Review.
AIM: To review microbiome alterations associated with pancreatic cancer, its potential utility in diagnostics, risk assessment, and influence on disease outcomes. ...Pre-clinical investigations exist in other tumor types that suggest microbiome manipulation provides opport …
AIM: To review microbiome alterations associated with pancreatic cancer, its potential utility in diagnostics, risk assessment, and i …
Clinical Trials and Progress in Metastatic Colon Cancer.
Mody K, Bekaii-Saab T. Mody K, et al. Surg Oncol Clin N Am. 2018 Apr;27(2):349-365. doi: 10.1016/j.soc.2017.11.008. Surg Oncol Clin N Am. 2018. PMID: 29496094 Review.
Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide but associated mortality has declined in recent decades. ...Further refinement based on molecular discoveries and the emergence of newer technologies to enable new discoveries allow for gr …
Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide but associated mortality has declined in recent …
Reactive oxygen species in cancer.
Liou GY, Storz P. Liou GY, et al. Free Radic Res. 2010 May;44(5):479-96. doi: 10.3109/10715761003667554. Free Radic Res. 2010. PMID: 20370557 Free PMC article. Review.
Elevated rates of reactive oxygen species (ROS) have been detected in almost all cancers, where they promote many aspects of tumour development and progression. However, tumour cells also express increased levels of antioxidant proteins to detoxify from ROS, suggesting tha …
Elevated rates of reactive oxygen species (ROS) have been detected in almost all cancers, where they promote many aspects of tumour d …
Oncolytic Viruses: Priming Time for Cancer Immunotherapy.
Russell L, Peng KW, Russell SJ, Diaz RM. Russell L, et al. BioDrugs. 2019 Oct;33(5):485-501. doi: 10.1007/s40259-019-00367-0. BioDrugs. 2019. PMID: 31321623 Free PMC article. Review.
New immuno-oncology therapies are improving cancer treatments beyond the former standard of care, as evidenced by the recent and continuing clinical approvals for immunotherapies in a broad range of indications. ...Moreover, many OVs can be engineered to express immunomodu …
New immuno-oncology therapies are improving cancer treatments beyond the former standard of care, as evidenced by the recent and cont …
Sexual dimorphism in the incidence of human cancers.
Zheng D, Trynda J, Williams C, Vold JA, Nguyen JH, Harnois DM, Bagaria SP, McLaughlin SA, Li Z. Zheng D, et al. BMC Cancer. 2019 Jul 12;19(1):684. doi: 10.1186/s12885-019-5902-z. BMC Cancer. 2019. PMID: 31299933 Free PMC article.
BACKGROUND: Sex differences in the incidences of cancers become a critical issue in both cancer research and the development of precision medicine. ...We provide a comprehensive analysis of sexual dimorphism in human cancers. METHODS: We analyzed four sets of …
BACKGROUND: Sex differences in the incidences of cancers become a critical issue in both cancer research and the development o …
Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma.
DeLeon TT, Ahn DH, Bogenberger JM, Anastasiadis PZ, Arora M, Ramanathan RK, Aqel BA, Vasmatzis G, Truty MJ, Oklu R, Bekaii-Saab TS, Borad MJ. DeLeon TT, et al. Future Oncol. 2018 Mar;14(6):553-566. doi: 10.2217/fon-2017-0451. Epub 2018 Feb 20. Future Oncol. 2018. PMID: 29460642 Review.
Worldwide hepatobiliary cancers are the second leading cause of cancer related death. Despite their relevance, hepatobiliary cancers have a paucity of approved systemic therapy options. ...Development of new and innovative therapies would help address the unm …
Worldwide hepatobiliary cancers are the second leading cause of cancer related death. Despite their relevance, hepatobiliary …
Dysplasia and Cancer in Inflammatory Bowel Disease.
Huang LC, Merchea A. Huang LC, et al. Surg Clin North Am. 2017 Jun;97(3):627-639. doi: 10.1016/j.suc.2017.01.010. Surg Clin North Am. 2017. PMID: 28501251 Review.
Inflammatory bowel disease is associated with an increased risk of dysplasia and cancer. Improvements in medical management and endoscopic surveillance have reduced these risks. Patients can develop cancer even in the absence of dysplasia or with indefinite or low-g …
Inflammatory bowel disease is associated with an increased risk of dysplasia and cancer. Improvements in medical management and endos …
Cancer in Sexual and Gender Minority Patients: Are We Addressing Their Needs?
Cathcart-Rake EJ. Cathcart-Rake EJ. Curr Oncol Rep. 2018 Sep 13;20(11):85. doi: 10.1007/s11912-018-0737-3. Curr Oncol Rep. 2018. PMID: 30209629 Review.
RECENT FINDINGS: Sexual and gender minorities suffer from cancer-related disparities, including lower rates of cancer screening, higher incidence of certain cancers, and higher cancer mortality rates. ...There is a paucity of literature guiding the …
RECENT FINDINGS: Sexual and gender minorities suffer from cancer-related disparities, including lower rates of cancer screenin …
Cholangiocarcinoma--controversies and challenges.
Patel T. Patel T. Nat Rev Gastroenterol Hepatol. 2011 Apr;8(4):189-200. doi: 10.1038/nrgastro.2011.20. Nat Rev Gastroenterol Hepatol. 2011. PMID: 21460876 Free PMC article. Review.
Cholangiocarcinomas are a diverse group of tumors that are presumed to originate from the biliary tract epithelium either within the liver or the biliary tract. These cancers are often difficult to diagnose, their pathogenesis is poorly understood, and their dismal prognos …
Cholangiocarcinomas are a diverse group of tumors that are presumed to originate from the biliary tract epithelium either within the liver o …
MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases.
Matsuda A, Yan IK, Foye C, Parasramka M, Patel T. Matsuda A, et al. Best Pract Res Clin Endocrinol Metab. 2016 Oct;30(5):577-590. doi: 10.1016/j.beem.2016.07.005. Epub 2016 Aug 1. Best Pract Res Clin Endocrinol Metab. 2016. PMID: 27923452 Free PMC article. Review.
In this overview, we review specific examples that will highlight the potential of miRNA to serve as paracrine signaling mediators in metabolic diseases and cancers. Elucidating the mechanisms involved in inter-cellular communication involving miRNA will provide new insigh …
In this overview, we review specific examples that will highlight the potential of miRNA to serve as paracrine signaling mediators in metabo …
29,825 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback